Toggle navigation
Home
Search
Services
Blog
Contact
About
Novel Beetle Luciferases for Biomedical Development
Wood, Keith V.
Promega Corporation, Madison, WI, United States
Search 9 grants from Keith Wood
Search grants from Promega Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Signaling in the retina and retinal pigment epithelium
Cooperative Multicenter Reproductive Medicine Network UNC Clinical Site
Abnormalities of Cardiac Glycogen Metabolism
Multiplexed DNA Sequencing Using Cge & Nir Fluorescence
Learning and Information
Recently added grants:
Core A Admin
Human mast cell and tissue acquisition core
Synthetic lethality screens in a nutrient sensitized Toxoplasma strain to identify novel proteins that mediate nutrient acquisition in chronic Toxoplasma infection.
Defining Siglec-6 and Siglec-8 function on effector cells of allergic diseases
Role of mTOR signaling in endothelial responses to Rickettsia rickettsii infection.
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44GM050623-03
Application #
2188586
Study Section
Special Emphasis Panel (ZRG7-SSS-2 (22))
Project Start
1993-09-30
Project End
1997-12-31
Budget Start
1996-07-01
Budget End
1997-12-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Promega Corporation
Department
Type
DUNS #
City
Madison
State
WI
Country
United States
Zip Code
53711
Related projects
NIH 1996
R44 GM
Novel Beetle Luciferases for Biomedical Development
Wood, Keith V. / Promega Corporation
NIH 1995
R44 GM
Novel Beetle Luciferases for Biomedical Development
Wood, Keith V. / Promega Corporation
Comments
Be the first to comment on this grant